Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Modified Research Career Development Award (K04)
Project #
7K04CA001222-01
Application #
3071765
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1985-08-01
Project End
1990-01-31
Budget Start
1985-08-01
Budget End
1986-01-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Rahman, M U; Mazumder, A (2001) The immunomodulatory effects of gentamicin, imipenem, piperacillin and amphotericin B on LAK effector function in vitro. FEMS Immunol Med Microbiol 30:249-52
Charak, B S; Agah, R; Mazumder, A (1993) Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation. Blood 81:3474-9
Charak, B S; Areman, E M; Dickerson, S A et al. (1993) A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application. Bone Marrow Transplant 11:147-54
Charak, B S; Brynes, R K; Chogyoji, M et al. (1993) Graft versus leukemia effect after transplantation with interleukin-2-activated bone marrow. Correlation with eradication of residual disease. Transplantation 56:31-7
Charak, B S; Agah, R; Mazumder, A (1992) Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood 80:179-84
Rahman, M U; Mazumder, A (1992) Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunothe J Clin Immunol 12:281-8
Charak, B S; Agah, R; Brynes, R K et al. (1992) Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective. Bone Marrow Transplant 9:479-86
Charak, B S; Sadowski, R M; Mazumder, A (1992) Antitumor effect of interferon plus cyclosporine A following chemotherapy for disseminated melanoma. Cancer Res 52:6482-6
Bean, P; Agah, R; Mazumder, A (1992) Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clones. Int J Cell Cloning 10:190-5
Charak, B S; Choudhary, G D; Tefft, M et al. (1992) Interleukin-2 in bone marrow transplantation: preclinical studies. Bone Marrow Transplant 10:103-11

Showing the most recent 10 out of 21 publications